Conditions & diseases

cell lung cancer

Observed in 118 articles across 14 journals.

Falling

Latest share0.13%

Change vs baseline-0.12 pp

Months observed13

Latest monthJul 2026

Portfolio article share

Attention over this snapshot

13 monthly points

Journal breadth

Where it appears

Journal for ImmunoTherapy of Cancer68
BMJ Case Reports11
BMJ Open8
Thorax8
BMJ Open Respiratory Research7
BMJ Oncology6
BMJ2
BMJ Supportive & Palliative Care2
BMJ Neurology Open1
European Journal of Hospital Pharmacy1
Gut1
Heart1

Co-occurrence

Explore nearby topics

Inspect the source signal

Article evidence

30 high-ranking examples

BMJ Case Reports · 2026-07-20

Occult diffuse jejunal metastasis from poorly differentiated non-small cell lung cancer mimicking immune checkpoint inhibitor enteritis

Phrase rank #1 · DOI 10.1136/bcr-2026-273774

BMJ Open Respiratory Research · 2026-07-10

Sing-a-Lung 2.0: protocol for a multicentre randomised controlled trial to investigate the effects and mechanisms of online-delivered singing training versus usual care 6–18 months after surgical resection for non-small cell lung cancer (NSCLC)

Phrase rank #1 · DOI 10.1136/bmjresp-2026-004382

BMJ Supportive & Palliative Care · 2026-06-29

Psychological distress and quality of life during chemotherapy for non-small cell lung cancer: prospective observational study

Phrase rank #1 · DOI 10.1136/spcare-2025-005463

Gut · 2026-06-26

IDDF2026-ABS-0145 Antibiotics and probiotics differentially shape immunotherapy outcomes in non-small cell lung cancer

Phrase rank #1 · DOI 10.1136/gutjnl-2026-IDDF.261

BMJ Oncology · 2026-06-23

Cost-effectiveness of neoadjuvant and adjuvant novel cancer therapies in stage II–III non-small cell lung cancer in Sri Lanka

Phrase rank #1 · DOI 10.1136/bmjonc-2025-001046

BMJ Oncology · 2026-05-21

Utilisation patterns of systemic anticancer therapy (SACT) in patients with advanced non-small cell lung cancer (NSCLC) in England

Phrase rank #1 · DOI 10.1136/bmjonc-2025-000957

Journal for ImmunoTherapy of Cancer · 2026-05-15

Phase I trial of CJRB-101 plus pembrolizumab in patients with metastatic non-small cell lung cancer, head and neck squamous cell carcinoma and melanoma

Phrase rank #1 · DOI 10.1136/jitc-2025-014702

BMJ Case Reports · 2026-04-24

Pseudocellulitis in a patient with non-small cell lung cancer on carboplatin, pemetrexed and pembrolizumab

Phrase rank #1 · DOI 10.1136/bcr-2025-269581

BMJ Case Reports · 2026-04-20

Tumour lysis syndrome following deliberately dose-reduced chemotherapy in extensive-stage small cell lung cancer with critical airway obstruction

Phrase rank #1 · DOI 10.1136/bcr-2026-272527

Thorax · 2026-04-17

Clustering by patients-related characteristics identifies specific phenotypes with different prognosis after resection of non-small cell lung cancer: a French nationwide study from the Epithor database

Phrase rank #1 · DOI 10.1136/thorax-2025-224424

BMJ Case Reports · 2026-04-02

Febrile neutropenia in a patient with non-small cell lung cancer treated with nivolumab

Phrase rank #1 · DOI 10.1136/bcr-2025-270744

Journal for ImmunoTherapy of Cancer · 2026-03-31

Clinical value of tumor mutational burden for neoadjuvant and adjuvant immune checkpoint inhibitor in early-stage non-small cell lung cancer

Phrase rank #1 · DOI 10.1136/jitc-2025-014168

BMJ Open · 2026-03-23

Safety and efficacy of intrathecal pemetrexed and bevacizumab in non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): protocol for a single-arm, prospective, phase Ia trial

Phrase rank #1 · DOI 10.1136/bmjopen-2026-116187

Thorax · 2026-03-13

Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study

Phrase rank #1 · DOI 10.1136/thorax-2025-223430

BMJ Oncology · 2026-02-19

SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

Phrase rank #1 · DOI 10.1136/bmjonc-2025-000890

Journal for ImmunoTherapy of Cancer · 2026-02-04

Neoadjuvant chemoimmunotherapy in non-small cell lung cancer: evolving resectability criteria, biomarker-driven postoperative management, and emerging therapeutic strategies

Phrase rank #1 · DOI 10.1136/jitc-2025-014098

BMJ Open Respiratory Research · 2026-01-20

Inhibition of GALNT7 suppresses cell proliferation and invasiveness while elevating cell apoptosis via the inactivation of the AKT pathway in non-small cell lung cancer

Phrase rank #1 · DOI 10.1136/bmjresp-2025-003560

Journal for ImmunoTherapy of Cancer · 2025-11-28